Susan Ott, M.D.

Metabolism, Endocrinology and Nutrition

Professor of Medicine

Focus

Clinical and bone histomorphometric studies of bone metabolism. Effects of contraception and lifestyle on bone density in adolescents; mineralization density of bone; bone histomorphometry of women with breast cancer; renal osteodystrophy.

Publications

Ott SM, Chesnut CH: Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 110:267-274, 1989.

Ott SM, Lipkin EW, Newell-Morris L: Bone physiology during pregnancy and lactation in young macaques. J Bone Mineral Res 14:1779-1788, 1999.

Ott SM, Oleksik A, Lu Y, Harper K, Lips P: Bone histomorphometric and biochemical marker results of a two-year placebo controlled trial of Raloxifene in postmenopausal women. J Bone Mineral Res 17:341-348, 2002.

Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM: Injectable hormone contraception and bone density: Results from a prospective study. Epidemiology 13:581-587, 2002.

Ott SM: Long-term safety of bisphosphonates. J Clin Endocrinol Metab 90:1897-1899, 2005.

Ott SM: Sclerostin and Wnt signaling–the pathway to bone strength. J Clin Endocrinol Metab 90:6741-6743, 2005.

Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G, Kidney Disease: Improving Global Outcomes (KDIGO): Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945-1953, 2006.

Other Website

Visit Dr. Ott’s osteoporosis web site at http://courses.washington.edu/bonephys.